The general consensus amongst sport and exercise genetics researchers is that genetic tests, based on current knowledge, do not meet the basic requirements of diagnostics and have little or no role to play in talent identification or individualised prescription of training to maximise performance.
The most commonly offered test is for the R577X variant in the ACTN3 gene sometimes called 'the speed gene". This accounts for at most only 2% of inter-individual variability in muscle strength or sprint speed. As an example of the value of this test, there are tens of millions of people living in the UK who have the genotype associated with sprint speed, but only a tiny fraction of those people will be elite sprinters.
There are currently many issues surrounding the information provided by the companies engaged in DTC genetic diagnostics for athletic talent or individualized exercise prescription:
 Exaggerated claims -claims of benefits not supported by scientific data are commonly used as inducements to pay for testing  Lack of disclosure -of the 39 companies identified worldwide offering this service 21/39 did not state which genes/markers were being tested  Quality control -For example, an independent report identified that samples of DNA from the same people were sent under different names and to different laboratories yet different gene variants were reported for the same individual.  Inducement to purchase expensive supplements -some companies offer nutritional and lifestyle information based upon limited and not-validated genetic diagnostics and the individual is encouraged to purchase multivitamin and mineral products at much higher prices than available on the market.  Consent -There is a consensus in the medical scientific community that genetic tests should be carried out only after the person concerned has given free and informed consent. This would include relevant information about the risks, benefits, limitations and implications of the genetic tests.  Ethical issues -the risks of genetic testing for talent identification may not be immediately obvious.
Psychological, social, and financial issues have been identified. For instance, the psychosocial consequences might include impaired self-esteem, social stigma, and, in terms of sport selection, may include employment limitation.
Consequently, in the current state of knowledge, no child or young athlete should be exposed to DTC genetic testing to define training regimens or to identify talented individuals for athletics.
This statement does not relate to genetic testing to identify people at risk for disease or for sudden cardiovascular events during exercise.
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